loader
Please Wait
Applying Filters...
menu
    • menu

    Quality Alerts: Granules Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets - Granules India Limited

    MenuGranules India Limited

    Uploaded: 2018
    News
    Granules India Receives FDA Warning Letter

    04 Mar 2025

    // FDA

    Granules India acquires Senn Chemical to foray into peptide & CDMO

    22 Feb 2025

    // INDPHARMAPOST

    Granules Strengthens ADHD Portfolio with FDA Approval

    30 Jan 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Granules India

    Contact Supplier

    Website

    DCAT Week

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/fBBQCpazbdc
    Xls

    CATEGORY PAGE
    Menu

    Granules India Limited

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100397